A 57-year-old Caucasian man (75 kg, 173 cm, BMI 25) was found to have clinical stage T2c prostate cancer (Gleason 3 + 4 = 7 on TRUS-guided biopsy, and PSA of 18 ng/dL). This evidence concerns the gene KLK3 and prostate carcinoma.